Estrogen induces the synthesis of vitellogenin mRNA by activating transcription of the vitellogenin genes. Quantitative inhibition of liver protein synthesis by cycloheximide does not prevent activation of vitellogenin gene transcription. The relative transcription rate of the vitellogenin genes in estrogen stimulated liver is similar in control and cycloheximide treated animals (800-1000 ppm). Selective estrogen activation of vitellogenin gene transcription therefore represents a direct effect of estrogen on viteliogenin gene transcription which can occur without any change in the cells' protein complement. Two other cellular responses to estrogen, the induction of nuclear estrogen receptor, and an increased rate of total nuclear RNA synthesis, are blocked by cycloheximide administration. Since the overall rate of vitellogenin mRNA synthesis is a function of both the selective estrogen activation of vitellogenin gene transcription which is not blocked by cycloheximide and the increased rate of total nuclear RNA synthesis which is blocked by cycloheximide, the total rate of vitellogenin mRNA synthesis is markedly reduced following cycloheximide administration.
INTRODUCTION
The induction by estrogen of the egg yolk precursor protein, vitellogenin, and its cognate mRNAs has proven a useful model system for studies of hormonally regulated gene expression (for reviews see 1-5). In the absence of estrogen, liver cells from male Xenopus laevis do not transcribe the four (3) vitellogenin genes (6). Estrogen administration results in an increase of at least several thousand fold in the relative and absolute rates of vitellogenin gene transcription (6) . The induction of vitellogenin mRNA (which ultimately reaches a level of approximately 50,000 molecules/cell Jjn_ vivo [7, 8] ) can be partially reproduced in organ culture (9-14) and does not appear to require ONA synthesis or cell division (10).
An important question in this and other hormone regulated systems is whether the stimulatory hormone exerts a direct early effect on gene expression (15) or acts indirectly by eliciting the production of regulatory gene products in a fashion similar to that first clearly described in the Drosophila ecdysone system (16) .
In this work we demonstrate that synthesis of new proteins is not a prerequisite for the selective estrogen activation of vitellogenin gene transcription. These data suggest that estrogen activation of vitellogenin gene transcription is a direct response to estrogen. We also
show that the accumulation of massive amounts of cytoplasmic vitellogenin mRNA, which depends on additional cellular processes which do not occur in the absence of protein synthesis, is dramatically reduced following cycloheximide administration.
METHODS
Male Xenopus laevis were obtained from Xenopus One, Ann Arbor, Michigan. Animals were injected with 2 mg estradiol (in propane-l,2-diol) to induce vitellogenesis and vitellogenin mRNA. Cycloheximide (dissolved in propane-l,2-diol) was injected one hour before estradiol. The methods used for extraction of total liver cell RNA, for preparation and characterization of vitellogenin cDNA, for hybridization of cDNA to RNA, for calculation of vitellogenin mRNA molecules per cell, for assay of estrogen receptor, and measurement of transcription rate were as we have described previously (6) (7) (8) 17, 18) . Briefly, total cell RNA was isolated by phenol-CHCl 3, SDS 1 extraction at alkaline pH and freed of ONA by repeated resuspension in 3 M sodium acetate (7, 8) .
The RNA was hybridized to 7-8 pg of vitellogenin cDNA (specific radioactivity 24 cpm/pg) and the proportion of the cDNA rendered double-stranded was determined following digestion of unhybridized singlestranded cONA with S} nuclease (7, 8) . Nuclear estrogen receptor was extracted from liver cell nuclei as we have described previously (17) and assayed for high-affinity estradiol binding by incubation with 3 H-estradiol-17g (98 Ci/mmol, Amersham). Separation of bound from free H-estradiol-17s was achieved on small columns of Sephadex-LH-20 (17, 20) .
The rate of vitellogenin gene transcription was determined by hybridizing pulse labeled RNA from liver cultures to cloned vitellogenin cDNA sequences immobilized on nitrocellulose filters (6, 19) . Labeling and hybridization were carried out exactly as we have described (6) . Liver cubes were pulse labeled for 45 min in culture medium containing 1 mCi/ml ^H-uridine (specific radioactivity 42 Ci/mmole). This labeling time was chosen as 10-15 min are hybridizing to immobilized vitellogenin DNA and total label incorporated into nuclear RNA yields the relative transcription rate. Determination of the specific radioactivity of cellular UTP pools was by our fPLC method (6) . The relative transcription rate and specific radioactivity of the UTP pools were used to calculate the absolute rates of both vitellogenin mRNA synthesis and total nuclear RNA synthesis (6) . The extent of inhibition of protein synthesis by cycloheximide was determined by injecting animals (in the dorsal lymph sac) with freshly prepared cycloheximide (10 yg/g body weight) dissolved in propylene glycol at 5 mg/ml. One, 4.5, or 10.5 hours later the animals received injections of 5 pCi/g body weight of ^H-leucine (New England Nuclear, 57.1 Ci/mmole; 2.5 mCi/ml in water, neutralized to pH 7). Livers were excised at the indicated times, homogenized in buffer (0.01 M Na-P04, pH 7.2; 0.15 M NaCl) and protein synthesis determined as trichloroacetic acid precipitable radioactivity (21) .
RESULTS

Cycloheximide Inhibition of Xenopus Protein Synthesis:
Preliminary experiments demonstrated that cycloheximide efficiently inhibited protein synthesis in Xenopus, without producing long-term toxic effects or mortality, at doses of 10 ug/g body weight (21) . Essentially quantitative inhibition of protein synthesis was achieved for at least 12 hours ( Table 1) . Inhibition of protein synthesis was complete whether incorporation of labeled leucine into protein was measured throughout the labeling period or during the last 1.5 hour of exposure to both cycloheximide and estrogen (Table 1, 
Relative Transcription Rate of the Vitellogenin Genes in Cycloheximide Treated Xenopus Liver:
We have recently demonstrated that the vitellogenin genes are not Male Xenopus were injected with cycloheximide (10 iig/g body weight). One hour later (T = U) animals received injections of either 2 mg estradiol-17ts or the propylene glycol vehicle alone.
3 H-leucine was administered at the indicated times and the cells were labeled for either 1.5 hr or 6 hr. Protein synthesis was determined by TCA precipitation.
transcribed at a significant rate in the absence of estrogen (6) . Following estrogen administration transcription of the vitellogenin genes begins in 2-4 hours and reaches a maximum of 600-1000 ppm in primary estrogen stimulation and 2,400 ppm in secondary estrogen stimulation (6) . These relative transcription rates represent the fraction of total nuclear RNA synthesis which is vitellogenin specific and allow a direct assessment of selective estrogen effects on vitellogenin gene transcription.
We therefore determined the relative transcription rate of the vitellogenin genes following inhibition of protein synthesis ( Table 2 ).
The elevated rate of vitellogenin mRNA accumulation (7, 8) and gene transcription (6) in secondary estrogen stimulation raises the possibility of the synthesis of stable regulatory factors during the initial response to estrogen. We therefore concentrated our studies on the conceptually simpler system prevailing in the primary estrogen response in which liver cells are Table 2 Effect of cycloheximide on the relative rate of vitellogenin gene transcription in estrogen stimulated liver.
Treatment
Relative Vitellogenin Transcription None Estrogen (12 hr) Cycloheximide + Estrogen ppm -0 900 950
Cycloheximide was administered at T=-l hr and estradiol-17ti at T=0 as described in "Methods" and the legend to Table 1 . Twelve hours later liver cubes were prepared and pulse labeled with J H-uridine. Nuclear RNA was isolated and hybridized to vitellogenin cDNA clones as we have described (6) . The relative transcription rate is the fraction (in parts per million) of total RNA synthesis (measured by TCA precipitation [6] ) devoted to viteliogenin transcription (measured by hybridization of pulse label nuclear RNA to vitellogenin cDNA clones immobilized on nitrocellulose filters). Data are corrected for length of cDNA probes and efficiency of hybridization (6) . Total RNA synthesis was 4.67>10 b CPM in the untreated control, 1.28-10 b CPM in estrogen treated liver and 5.5-10 4 CPM in liver treated with cycloheximide followed by estrogen. Values of less than 1.5 CPM are considered ~0. exposed to estrogen for the first time. The data in Table 2 demonstrate that even in the complete absence of protein synthesis for 12 hours, maximal activation of vitellogenin gene transcription is achieved. Thus selective activation of vitellogenin gene transcription can occur without synthesis of new cellular proteins. In order to demonstrate that viteliogenin transcripts produced in estrogen stimulated, cycloheximide treated, liver cells exit the nucleus and actually accumulate in the cells, we quantitated cellular vitellogenin mRNA levels by solution hybridization. Induction of vitellogenin mRNA in the absence of protein synthesis:
Estradiol-178 was administered to male Xenopus laevis one hour after injection of a level of cycloheximide (10 pg/g body weight) which quantitatively inhibits protein synthesis ( Table 1) . The animals were killed at the indicated times, liver mRNA was extracted and vitellogenin mRNA content determined by RNA excess hybridization to vitellogenin cDNA (7). The estrogen induction of vitellogenin mRNA (which is absent in control liver, Figure 1 and [7, 8] ) and its progressive accumulation in liver cells from cycloheximide treated animals is shown in Figure 1 . New vitellogenin mRNA sequences appeared both in liver cells which had never expressed these genes before (Fig. 1, Table 3 ). These data demonstrate that accumulation of vitellogenin mRNA and maintenance of the difference in accumulation rates between primary and secondary estrogen stimulation are not dependent upon de novo protein synthesis. However, the actual rate of vitellogenin mRNA accumulation in cycloheximide treated animals was only about 10% of the rate in animals treated with estrogen alone (Table  3; Table 3 of vitellogenin mRNA and nuclear estrogen cycloheximide and estradio1-17p. The data for molecules of vitellogenin mRNA/cell was calculated (7, 8 ) from the C r t curves of Fig. 1 . Nuclear estrogen receptor levels in livers of the same animals were determined as described previously (17) . a determined separately.
of estrogen stimulated liver cells is a function of at least 3 estrogen mediated nuclear processes: (A) Selective activation of vitellogenin gene transcription (6); (B) Induction of nuclear estrogen receptor (17,18,23); (C) Induction of a total nuclear RNA synthesis which increases 20-60 fold in estrogen stimulated cells (6) . Since inhibition of protein synthesis was without effect on the selective activation of vitellogenin gene transcription (Table 2 ) while the rate of cytoplasmic accumulation of vitellogenin mRNA was markedly reduced (Fig. 1) , we examined the effects of protein synthesis inhibition on the induction of nuclear estrogen receptor and total RNA synthesis.
The induction of vitellogenin mRNA is accompanied by an increase of 3-4 fold in the level of nuclear estrogen receptor (17, 18) . Inhibition of protein synthesis by cycloheximide quantitatively blocks the increase in nuclear estrogen receptor levels (Table 3 ) which otherwise would rise from 500 to approximately 2,000 sites/cell within 12 hours of estrogen stimulation (17, 18) . These data suggest that selective activation of vitellogenin gene transcription can be achieved by binding of estrogen to pre-existing nuclear estrogen receptor.
We have recently shown that primary estrogen stimulation induces an Table 4 Effect of cvcloheximide on total RNA synthesis and on the absolute rate of vitellogenin RNA synthesis in estrogen stimulated liver. Total RNA synthesis is calculated from the amount of label incorporated into nuclear RNA (which is determined by TCA precipitation) and the specific radioactivity of the cellular UTP pool (which is determined by HPLC [6] ). The absolute rate of nuclear RNA synthesis is presented as picomoles of UTP incorporated into RNA/10° cells/min (6) . The absolute rate of vitellogenin RNA synthesis is calculated from the relative rate of vitellogenin gene transcription, the specific radioacticity of the cellular UTP pool (51 CPM/pmole in estradiol treated liver, 333 CPM/pmole in liver cells treated with E2 + CHX), and the base composition of vitellogenin mRNA as we describe elsewhere (6) . The increased specific radioactivity of the cellular UTP pool in cells treated with CHX and E 2 is due to a several fold decline in the size of nucleotide triphosphate pools in these cells (see text).
increase of about 60 fold in the absolute rate of nuclear RNA synthesis (6) .
Since the relative rate of vitellogenin gene transcription is unaltered by cycloheximide (Table 2) , it seemed likely that overall transcription must be depressed under these conditions. Following estrogen administration the absolute rate of total nuclear RNA synthesis increased 75 fold (Table 4 ). The data (Table 4) demonstrate that the increase in total nuclear RNA synthesis is abolished in cycloheximide treated animals 12 hours after estrogen. The low rate of vitellogenin mRNA accumulation in the cytoplasm of cycloheximide treated cells is therefore due to the fact that the selective estrogen activation of vitellogenin gene transcription which is normal in these cells (Table 2) , is not accompanied by a burst of total nuclear RNA synthesis (Table   4 ). At this time we have not conclusively determined whether the abolition of the estrogen mediated rise in nuclear RNA synthesis by cycloheximide administration represents a genuine requirement for protein syntheis, or is a secondary effect due to impaired energy metabolism in the absence of protein synthesis. Our highly preliminary data show that the burst of nuclear RNA synthesis following estrogen stimulation is accompanied by a rise in cellular nucleotide triphosphate levels (M. Brock and D. Shapiro, unpublished observations). The elevated levels of nucleotide triphosphates would tend to saturate RNA polymerase with substrate and increase its activity. The ATP pool size in liver cells treated with estrogen and cycloheximide for 12 hours was determined by HPLC and was 5 times smaller than the ATP pool size in estrogen treated animals. These data suggest that a general metabolic effect which prevents the increase in nucleotide triphosphate pool sizes rather than a specific requirement for protein synthesis may be primarily responsible for the blockage of the induction of total RNA synthesis by cycloheximide. (Table III) , the additional nuclear receptor appears to represent new receptor synthesis. Quantitative (> 98%) cycloheximide inhibition of protein synthesis prior to estrogen administration blocks both the increase in total nuclear RNA synthesis and the induction of nuclear estrogen receptor, but does not prevent the induction of vitellogenin gene transcription, which rises from undetectable levels to approximately 900 ppm ([6], Table 2 ), the same relative rate of transcription observed in control Xenopus. This type of direct hormone effect on the transcription of a particular gene has been demonstrated in the dexamethasone/MMTV system (24) and in the thyroid hormone -dexamethasone regulation of growth hormone gene transcription (27) . In these studies, only the relative rate of specific gene expression was examined.
DISCUSSION
In the growth hormone system, cycloheximide administration actually raises the relative rate of gene transcription (27) . This observation lends support to the hypothesis that desensitization of cells, which results in a reduced response to hormones, is mediated by proteins synthesized in response to hormone (27,28). One possible explanation for the reduced rate of vitellogenin gene transcription in primary estrogen stimulation relative to secondary stimulation is that newly synthesized proteins, synthesized during the primary estrogen response, limit the rate of transcription. Our data (Table 2) demonstrate that the relative rate of vitellogenin gene transcription in primary estrogen stimulation is not changed by inhibition of protein synthesis and remains several fold lower than the rate in secondary estrogen stimulation (6).
Interpretations of experiments involving the use of protein synthesis inhibitors are often complicated by secondary toxic effects of these compounds. The failure to observe a biological response following administration of cycloheximide may therefore represent either a requirement for protein synthesis in that response, or abolition of the response due to overall systemic toxicity. Only if two conditions are met can experiments involving the use of protein synthesis inhibitors be subject to straightforward interpretation. (A) The extent of inhibition of protein synthesis must be essentially quantitative so that residual protein synthesis cannot be responsible for the observed biological response. (B) The biological response must occur in the absence of protein synthesis so that alternative interpretations are not possible. Both of these criteria are met in the failure of quantitative inhibition of protein synthesis by cycloheximide to inhibit the selective activation of vitellogenin gene transcription ( Table 2 ).
The accumulation of massive amounts of cytoplasmic vitellogenin messenger RNA requires both the selective activation of vitellogenin gene transcription and an overall induction of total nuclear RNA synthesis. The induction of nuclear RNA synthesis is blocked in cycloheximide treated animals, leading to a dramatic reduction in the rate of accumulation of vitellogenin mRNA in these animals. Our observation that cellular ATP pools are approximately 5 fold lower in cycloheximide treated animals and related observations suggesting that an increase in nucleotide triphosphate pools plays a significant role in the burst of RNA synthesis which follows estrogen stimulation suggest, but do not prove, that secondary toxic effects of cycloheximide may play a substantial role in blockage of the induction of total nuclear RNA synthesis.
These observations complement our previous studies of the kinetics of vitellogenin mRNA accumulation (7, 8) which demonstrated the rapid appearance of vitellogenin mRNA following primary and secondary estrogen stimulation. Our data demonstrate that the estrogen activation of vitellogenin gene transcription is properly characterized as a direct early response to estrogen. These studies have also allowed us to dissociate the various cellular responses to estradiol-17g and have enabled us to demonstrate that neither the induction of additional nuclear estrogen receptor nor the increase in overall nuclear RNA synthesis are obligatory prerequisites for the activation of vitellogenin gene transcription.
